Manufacturer of Controlled Substances Notice of Registration, 10675-10676 [05-4212]
Download as PDF
<![CDATA[
10675
Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices
interstate or foreign commerce, subject
to subsection (b).
(b) This section shall not be construed
to supersede or limit the laws of any
State that—
(1) Permit private persons or entities
to prohibit or restrict the possession of
concealed firearms on their property; or
(2) Prohibit or restrict the possession
of firearms on any State or local
government property, installation,
building, base, or park.
(c) As used in this section, the term
‘‘qualified retired law enforcement
officer’’ means an individual who—
(1) Retired in good standing from
service with a public agency as a law
enforcement officer, other than for
reasons of mental instability;
(2) Before such retirement, was
authorized by law to engage in or
supervise the prevention, detection,
investigation, or prosecution of, or the
incarceration of any person for, any
violation of law, and had statutory
powers of arrest;
(3)(A) Before such retirement, was
regularly employed as a law
enforcement officer for an aggregate of
15 years or more; or
(B) Retired from service with such
agency, after completing any applicable
probationary period of such service, due
to a service-connected disability, as
determined by such agency;
(4) Has a nonforfeitable right to
benefits under the retirement plan of the
agency;
(5) During the most recent 12-month
period, has met, at the expense of the
individual, the State’s standards for
training and qualification for active law
enforcement officers to carry firearms;
(6) Is not under the influence of
alcohol or another intoxicating or
hallucinatory drug or substance; and
(7) Is not prohibited by Federal law
from receiving a firearm.
(d) The identification required by this
subsection is—
(1) A photographic identification
issued by the agency from which the
individual retired from service as a law
enforcement officer that indicates that
the individual has, not less recently
than one year before the date the
individual is carrying the concealed
firearm, been tested or otherwise found
by the agency to meet the standards
established by the agency for training
and qualification for active law
enforcement officers to carry a firearm
of the same type as the concealed
firearm; or
(2)(A) A photographic identification
issued by the agency from which the
individual retired from service as a law
enforcement officer; and
(B) Certification issued by the State in
which the individual resides that
VerDate jul<14>2003
19:07 Mar 03, 2005
Jkt 205001
indicates that the individual has, not
less recently than one year before the
date the individual is carrying the
concealed firearm, been tested or
otherwise found by the State to meet the
standards established by the State for
training and qualification for active law
enforcement officers to carry a firearm
of the same type as the concealed
firearm.
(e) As used in this section, the term
‘firearm’ does not include—
(1) Any machinegun (as defined in
section 5845 of the National Firearms
Act);
(2) Any firearm silencer (as defined in
section 921 of this title); and
(3) A destructive device (as defined in
section 921 of this title).’’
118 Stat. at 866–67.
Under these provisions, a person is a
retired qualified LEO under the Act if he
or she (1) retired in good standing from
his or her employing agency (other than
for reasons of mental instability); (2)
was authorized to perform the specified
law enforcement functions and held a
position for which powers of arrest were
granted by statute; (3) was regularly
employed as a law enforcement officer
for an aggregate of 15 years or more
before his or her retirement, or retired
from service with his or her agency
(after completing any applicable
probationary period of such service) due
to a service-connected disability as
determined by the agency; (4) has a nonforfeitable right to retirement plan
benefits of the law enforcement agency;
(5) during the most recent year, has met
state firearms training and qualifications
that are the same as the training and
qualifications for active duty officers; (6)
is not under the influence of alcohol or
another intoxicating or hallucinatory
drug or substance; (7) is not prohibited
by Federal law from receiving a firearm;
(8) carries a photo identification issued
by the agency; and (9) meets an annual
qualification requirement.
The Department considers the
following components to be agencies
whose retired employees may qualify as
LEOs for purposes of the Act: the
Bureau of Alcohol, Tobacco, Firearms,
and Explosives; the Drug Enforcement
Administration; the Federal Bureau of
Investigation; the Federal Bureau of
Prisons; the Office of Inspector General,
insofar as the retiree exercised statutory
law enforcement authority at the time of
his retirement; and the United States
Marshals Service. As with current
employees, any particular retired
employee of one of these components
independently must meet each of the
specified statutory qualifications to
qualify as a retired LEO under the Act.
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Each affected component separately
shall prepare and issue a photographic
identification card for qualified retired
LEOs. Each such identification card
shall, at a minimum, include the name
of the individual, the individual’s
photograph, an identification number
traceable to the bearer, the date the
employee retired in good standing from
service with the issuing agency, and the
phrase ‘‘Retired Law Enforcement
Officer.’’
Individual components shall not
themselves train or qualify retired
employees to carry a firearm, as
authorized under the law. In order to be
authorized under the Act to carry a
firearm, a retired qualified LEO from a
DOJ component must qualify pursuant
to 18 U.S.C. 926C(d)(2)(B), and in
accordance with state standards for
active LEOs.
It shall be within the discretion of the
employing agency to issue the retired
LEO credential called for under the Act.
Should the agency (1) make a finding
that the subject is not qualified, or (2)
enter into an agreement in which the
subject agrees that he or she is not
qualified, the subject shall not be issued
the retired LEO credential described
above.
With respect to the Act’s limitation
that a qualified retired LEO ‘‘is not
under the influence of alcohol or
another intoxicating or hallucinatory
drug or substance,’’ each former
Department employee seeking such
qualification annually must meet state
standards, if any, regarding alcohol or
drug use by law enforcement officers
authorized to carry a firearm.
[FR Doc. 05–4282 Filed 3–3–05; 8:45 am]
BILLING CODE 4410–20–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated October 1, 2004, and
published in the Federal Register on
October 29, 2004, (69 FR 63178),
Cambrex North Brunswick Inc.,
Technology Center of New Jersey, 661
Highway One, North Brunswick, New
Jersey 08902, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedules I and II:
Drug
N-Ethylamphetamine (1475) ........
Tetrahydrocannabinols (7370) .....
E:\FR\FM\04MRN1.SGM
04MRN1
Schedule
I
I
10676
Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices
Drug
Schedule
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
4-Methoxyamphetamine (7411) ...
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Codeine (9050) .............................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone Intermediate (9254) ...
Morphine (9300) ...........................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
I
I
I
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambrex North Brunswick, Inc.,
Technology Centre of New Jersey to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Cambrex North Brunswick,
Inc., Technology Centre of New Jersey to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
DEPARTMENT OF JUSTICE
By Notice dated September 16, 2004,
and published in the Federal Register
on September 30, 2004, (69 FR 58539–
58540), Cambridge Isotope Laboratory,
50 Frontage Road, Andover,
Massachusetts 01810, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedules I and II:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated September 28, 2004
and published in the Federal Register
on October 14, 2004, (69 FR 61043),
Cambrex North Brunswick, Inc.,
Technology Center of New Jersey, 661
Highway One, North Brunswick, New
Jersey 08902, made application by
renewal to the Drug Enforcement
Jkt 205001
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances; Notice of Registration
BILLING CODE 4410–09–P
19:07 Mar 03, 2005
Dated: February 23, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4235 Filed 3–3–05; 8:45 am]
Drug Enforcement Administration
Dated: February 23, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4212 Filed 3–3–05; 8:45 am]
VerDate jul<14>2003
Administration (DEA) to be registered as
an importer of Phenylacetone (8501), a
basic class of controlled substance listed
in Schedule II.
The company plans to import the
listed controlled substances to
manufacture amphetamine.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. sections 823(a) and
952(a) and determined that the
registration of Cambrex North
Brunswick, Inc. to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Cambrex North Brunswick, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
sections 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the
above named company is granted
registration as an importer of the basic
class of controlled substance listed.
Drug
Schedule
Methaqualone (2565) ...................
Dimethyltryptamine (7435) ...........
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
I
I
II
II
II
II
Drug
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Methadone (9250) ........................
Dextropropoxyphene (9273) .........
Morphine (9300) ...........................
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to produce isotope labeled
standards for drug analysis.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambridge Isotope Laboratory to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Cambridge Isotope
Laboratory to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: February 22, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4204 Filed 3–3–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated September 28, 2004,
and published in the Federal Register
on October 14, 2004, (69 FR 61043),
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78664, made application by renewal to
the Drug Enforcement Administration
(DEA) for registration as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 70, Number 42 (Friday, March 4, 2005)]
[Notices]
[Pages 10675-10676]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4212]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Registration
By Notice dated October 1, 2004, and published in the Federal
Register on October 29, 2004, (69 FR 63178), Cambrex North Brunswick
Inc., Technology Center of New Jersey, 661 Highway One, North
Brunswick, New Jersey 08902, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475).................. I
Tetrahydrocannabinols (7370)............... I
[[Page 10676]]
2,5-Dimethoxyamphetamine (7396)............ I
3,4-Methylenedioxyamphetamine (7400)....... I
4-Methoxyamphetamine (7411)................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Codeine (9050)............................. II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Methadone Intermediate (9254).............. II
Morphine (9300)............................ II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cambrex North Brunswick, Inc., Technology Centre of New Jersey to
manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated
Cambrex North Brunswick, Inc., Technology Centre of New Jersey to
ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823, and in
accordance with 21 CFR 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: February 23, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-4212 Filed 3-3-05; 8:45 am]
BILLING CODE 4410-09-P
